Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia
ALL-BFM 2000 Multi-Center Study for the Treatment of Children and Adolescents With Acute Lymphoblastic Leukemia
Sponsor: University Hospital Schleswig-Holstein
Listed as NCT00430118, this PHASE3 trial focuses on Leukemia and remains completed. Sponsored by University Hospital Schleswig-Holstein, it has been updated 7 times since 2000, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Nov 2020 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 2 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Completed PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Jul 2000
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital Schleswig-Holstein
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aachen, Germany , Aarau, Switzerland , Augsburg, Germany , Bad Mergentheim, Germany , Basel, Switzerland , Bayreuth, Germany , Berlin, Germany , Bonn, Germany , Braunschweig, Germany , Chemnitz, Germany and 63 more locations